William Sullivan, Former President & CEO BW USA

Joined company as General Counsel in 1973 and became President in 1981.

Topics covered include:

* corporate culture

* management of research

* management style

* pricing, generally and specifically of Retrovir and Lanoxin

* marketing, generally approach to and development of, looking at Sudafed and Actifed specifically

* legal case regarding building in Research Triangle Park, North Carolina

* Drug Regulation and the FDA [Food and Drug Administration]

* Patents

* strategic review of the company including the McKinsey Report

* relationship between UK and US companies

* possible Joint Venture with Gillette

* flotation

2 audiocassettes Tape 6

Copyright was assigned to the Wellcome Trust for all material created or commissioned by the Wellcome Foundation, its successors and associated companies. The copyright in third party material (ie material not created by WF such as letters and publications from external sources, magazine articles, newspaper cuttings etc) is assumed to remain with the creator or his/her heirs. Where third party material exists, this has been noted at item level.

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.